GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors

• David G DeNardo,
• Johanna Bendell,
• Lei Zhou,
• Jakob Dupont,
• Anna Galkin

Affiliations

David G DeNardo

Department of Medicine, ICCE Institute, Department of Pathology and Immunology, Siteman Cancer Center, Washington University in Saint Louis School of Medicine, Saint Louis, Missouri, USA

Johanna Bendell

Sarah Cannon Research Institute, Tennessee Oncology, Nashville, Tennessee, USA

Lei Zhou

School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China

Jakob Dupont

Gossamer Bio, San Diego, California, USA

Anna Galkin

Gossamer Bio, San Diego, California, USA